CHAMBLFERT - Fundamental Analysis: Financial Health & Valuation

Last Updated Time : 05 Nov 25, 7:43 am

Fundamental Rating: 4.4

📈 Positive

• 💰 Zero debt (Debt-to-equity: 0.00) ensures strong financial health and minimal risk exposure.
• 📊 High ROCE (27.6%) and ROE (20.3%) reflect efficient capital deployment and profitability.
• 📈 Quarterly PAT surged to ₹638 Cr. from ₹99.7 Cr., indicating strong operational performance.
• 💸 Dividend yield of 2.04% offers attractive passive income for long-term investors.
• 📉 Low P/E of 11.0 compared to industry average of 22.7 suggests undervaluation.
• 📈 EPS of ₹43.5 supports strong earnings visibility.

⚠️ Limitation

• 📉 PEG ratio of 1.47 indicates moderate growth relative to valuation.
• 📉 Trading below DMA50 and DMA200 (₹517 and ₹538), signaling bearish technical trend.
• 📉 RSI at 37.2 and MACD at -10.7 reflect weak momentum and oversold conditions.
• 📉 DII holding declined by 2.56%, showing reduced domestic institutional interest.

📰 Company Negative News

• 📉 Stock down 10.1% from 52-week high, reflecting market caution or sectoral pressure.
• 📉 Technical indicators weak despite strong fundamentals, suggesting short-term downside risk.

🌟 Company Positive News

• 📈 FII holding increased by 1.23%, indicating rising foreign investor confidence.
• 📈 Volume above 1-week average suggests renewed interest and potential accumulation.

🌾 Industry

• 🌿 CHAMBLFERT operates in the fertilizers and agrochemicals sector, benefiting from rural demand and government support.
• 📊 Industry P/E of 22.7 reflects moderate growth expectations and cyclical exposure to commodity pricing.

🧭 Conclusion

• 📌 Suggested entry zone: ₹460–₹480, near support and below moving averages for better margin of safety.
• 🕰️ Long-term holding attractive due to strong fundamentals, zero debt, and high return ratios.
• ⚖️ Monitor technical recovery and institutional flows for confirmation of trend reversal.